Literature DB >> 22395797

The prevalence of primary headache disorders in Russia: a countrywide survey.

I Ayzenberg1, Z Katsarava, A Sborowski, M Chernysh, V Osipova, G Tabeeva, N Yakhno, T J Steiner.   

Abstract

OBJECTIVE: To estimate the 1-year prevalences of primary headache disorders and identify their principal risk factors in the general population of Russia.
METHODS: A countrywide population-based random sample of 2725 biologically unrelated adults in 35 cities and nine rural areas were interviewed in a door-to-door survey using a previously validated diagnostic questionnaire.
RESULTS: Of the 2725 eligible adults contacted, 2025 (74.3%) responded (females 52.6%, mean age 39.5 ± 13.4 years). Of these, 1273 (62.9%) reported headache 'not related to flu, hangover, cold, head injury' occurring at least once in the previous year. The gender- and age-standardized 1-year prevalence of migraine was 20.8%. Female gender (odds ratio (OR) = 3.8; 95% confidence interval (CI) 2.8-5.1) and obesity (OR = 1.5; 1.1-2.1) were positively associated with this type of headache. The gender- and age-standardized 1-year prevalence of tension-type headache (TTH) was 30.8%. TTH was more prevalent in urban than in rural areas (OR = 1.6; 1.3-2.0). Headache on ≥15 days/month was reported by 213 (10.5%) respondents (gender- and age-standardized prevalence 10.4%), and associated with low socioeconomic status (OR = 3.4; 2.4-4.9), obesity (OR = 3.0; 2.1-4.3), female gender (OR = 2.9; 2.1-4.1) and age over 40 years (OR = 2.6; 1.9-3.6). The majority of these respondents (68.1%) overused acute headache medications.
CONCLUSION: The study demonstrated a high prevalence of migraine and a very high prevalence of headache on  ≥15 days/month, and revealed unmet health-care needs of people with headache in Russia.

Entities:  

Mesh:

Year:  2012        PMID: 22395797     DOI: 10.1177/0333102412438977

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  42 in total

Review 1.  Medication overuse headache.

Authors:  Valerie Cheung; Farnaz Amoozegar; Esma Dilli
Journal:  Curr Neurol Neurosci Rep       Date:  2015-01       Impact factor: 5.081

Review 2.  Medication-overuse headache: a perspective review.

Authors:  Maria Lurenda Westergaard; Signe Bruun Munksgaard; Lars Bendtsen; Rigmor Højland Jensen
Journal:  Ther Adv Drug Saf       Date:  2016-06-30

3.  The PACE study: lifetime and past-year prevalence of headache in Parma's adult general population.

Authors:  Arens Taga; Marco Russo; Gian Camillo Manzoni; Paola Torelli
Journal:  Neurol Sci       Date:  2017-02-17       Impact factor: 3.307

Review 4.  Medication Overuse Headache: The Reason of Headache That Common and Preventable.

Authors:  Elif Kocasoy Orhan; Betül Baykan
Journal:  Noro Psikiyatr Ars       Date:  2013-08-01       Impact factor: 1.339

5.  Prevalence of headache in patients with Parkinson's disease and its association with the side of motor symptom onset.

Authors:  Jean Costa Nunes; E N Costa Bergamaschi; F C Freitas; A P Diaz; L P Queiroz; R Debona; R D S Prediger; M N Linhares; K Lin; Roger Walz
Journal:  Neurol Sci       Date:  2013-11-07       Impact factor: 3.307

Review 6.  Ketoprofen for episodic tension-type headache in adults.

Authors:  Lucy Veys; Sheena Derry; R Andrew Moore
Journal:  Cochrane Database Syst Rev       Date:  2016-09-22

Review 7.  Sumatriptan plus naproxen for the treatment of acute migraine attacks in adults.

Authors:  Simon Law; Sheena Derry; R Andrew Moore
Journal:  Cochrane Database Syst Rev       Date:  2016-04-20

Review 8.  Medication-overuse headache: risk factors, pathophysiology and management.

Authors:  Hans-Christoph Diener; Dagny Holle; Kasja Solbach; Charly Gaul
Journal:  Nat Rev Neurol       Date:  2016-09-12       Impact factor: 42.937

9.  The PACE study: past-year prevalence of tension-type headache and its subtypes in Parma's adult general population.

Authors:  T Ferrante; G C Manzoni; M Russo; A Taga; C Camarda; L Veronesi; C Pasquarella; G Sansebastiano; P Torelli
Journal:  Neurol Sci       Date:  2014-08-11       Impact factor: 3.307

Review 10.  Naproxen with or without an antiemetic for acute migraine headaches in adults.

Authors:  Simon Law; Sheena Derry; R Andrew Moore
Journal:  Cochrane Database Syst Rev       Date:  2013-10-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.